PubRank

International journal of hepatology (Int J Hepatol)

Journal PubWeight™ 185.49‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Clinicopathological features and treatment of ectopic varices with portal hypertension. 2011 1.87
2 APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review. 2011 1.24
3 Non-invasive radiofrequency-induced targeted hyperthermia for the treatment of hepatocellular carcinoma. 2011 1.23
4 Intraductal papillary neoplasms of the bile duct. 2014 1.14
5 Radiofrequency ablation of hepatocellular carcinoma: a literature review. 2011 1.13
6 Hepatic angiomyolipoma: diagnostic findings and management. 2012 1.12
7 MicroRNA Signature in Alcoholic Liver Disease. 2012 1.12
8 Management of anticoagulation for portal vein thrombosis in individuals with cirrhosis: a systematic review. 2012 1.08
9 Hepatocellular carcinoma: current management and future development-improved outcomes with surgical resection. 2011 1.06
10 Oxidative stress and inflammation: essential partners in alcoholic liver disease. 2012 1.05
11 Molecular pathogenesis of cholangiocarcinoma. 2011 1.02
12 Mechanisms and biomarkers of apoptosis in liver disease and fibrosis. 2012 1.02
13 The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension: current status. 2012 1.00
14 Biomarkers for hepatocellular carcinoma. 2012 1.00
15 Targeting the HGF-cMET Axis in Hepatocellular Carcinoma. 2013 0.99
16 Cell signals influencing hepatic fibrosis. 2012 0.98
17 Liver resection after downstaging hepatocellular carcinoma with sorafenib. 2011 0.98
18 Functional Relationships between Lipid Metabolism and Liver Regeneration. 2012 0.97
19 Caroli's Disease: Current Knowledge of Its Biliary Pathogenesis Obtained from an Orthologous Rat Model. 2011 0.96
20 Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again. 2012 0.96
21 Acute Liver Failure Caused by Amanita phalloides Poisoning. 2012 0.95
22 CYP2E1 Sensitizes the Liver to LPS- and TNF α-Induced Toxicity via Elevated Oxidative and Nitrosative Stress and Activation of ASK-1 and JNK Mitogen-Activated Kinases. 2011 0.95
23 Mystery of hepatitis e virus: recent advances in its diagnosis and management. 2015 0.95
24 Etiopathogenesis of nonalcoholic steatohepatitis: role of obesity, insulin resistance and mechanisms of hepatotoxicity. 2012 0.95
25 A multimodal approach to the management of neuroendocrine tumour liver metastases. 2012 0.94
26 Betaine treatment attenuates chronic ethanol-induced hepatic steatosis and alterations to the mitochondrial respiratory chain proteome. 2011 0.93
27 IgG4 Cholangiopathy. 2011 0.93
28 Markers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis C. 2012 0.93
29 HIV-Antiretroviral Therapy Induced Liver, Gastrointestinal, and Pancreatic Injury. 2012 0.93
30 Liver injury induced by anticancer chemotherapy and radiation therapy. 2013 0.93
31 Liver Surgery for Hepatocellular Carcinoma: Laparoscopic versus Open Approach. 2011 0.92
32 A case of a ruptured sclerosing liver hemangioma. 2011 0.92
33 Serum NGAL to Clinically Distinguish Cholangiocarcinoma from Benign Biliary Tract Diseases. 2010 0.92
34 Experience Since MELD Implementation: How Does the New System Deliver? 2012 0.92
35 What are the precursor and early lesions of peripheral intrahepatic cholangiocarcinoma? 2014 0.92
36 Neuroendocrine Liver Metastases and Orthotopic Liver Transplantation: The US Experience. 2011 0.92
37 The Link between Hypersensitivity Syndrome Reaction Development and Human Herpes Virus-6 Reactivation. 2012 0.91
38 Hepatocytes polyploidization and cell cycle control in liver physiopathology. 2012 0.91
39 Circulating tumor cells measurements in hepatocellular carcinoma. 2012 0.91
40 New Insights into the Pathogenesis of Alcohol-Induced ER Stress and Liver Diseases. 2014 0.90
41 Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review. 2011 0.90
42 Fructose induced endotoxemia in pediatric nonalcoholic Fatty liver disease. 2014 0.90
43 The molecular pathogenesis and clinical implications of hepatocellular carcinoma. 2011 0.89
44 A current review of the diagnostic and treatment strategies of hepatic encephalopathy. 2012 0.88
45 Indications and contraindications for liver transplantation. 2011 0.88
46 A Primer on Detecting Cirrhosis and Caring for These Patients without Causing Harm. 2011 0.88
47 The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control. 2012 0.88
48 Pathophysiology of portal hypertension and esophageal varices. 2012 0.87
49 Diagnosis and management of giant hepatic hemangioma: the usefulness of contrast-enhanced ultrasonography. 2013 0.87
50 Alcohol Activates TGF-Beta but Inhibits BMP Receptor-Mediated Smad Signaling and Smad4 Binding to Hepcidin Promoter in the Liver. 2011 0.87
Next 50